Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.

Arch Neurol. 2012 Jul;69(7):836-41.

3.

Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya.

Simpson KN, Baran RW, Kirbach SE, Dietz B.

Value Health. 2011 Dec;14(8):1048-54. doi: 10.1016/j.jval.2011.06.011. Epub 2011 Nov 6.

4.

Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study.

Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP.

Arthritis Rheum. 2011 Nov;63(11):3294-304. doi: 10.1002/art.30581.

5.

A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.

Kirbach S, Simpson K, Nietert PJ, Mintzer J.

Clin Drug Investig. 2008;28(5):291-303.

PMID:
18407715
6.

NMDA receptors and the differential ischemic vulnerability of hippocampal neurons.

Gee CE, Benquet P, Raineteau O, Rietschin L, Kirbach SW, Gerber U.

Eur J Neurosci. 2006 May;23(10):2595-603.

PMID:
16817862
7.

Substrate mimetics and freezing strategy: a useful combination that broadens the scope of proteases for synthesis.

Wehofsky N, Kirbach SW, Haensler M, Wissmann JD, Bordusa F.

Org Lett. 2000 Jul 13;2(14):2027-30.

PMID:
10891221

Supplemental Content

Loading ...
Support Center